UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044752
Receipt number R000050491
Scientific Title Study on the pathophysiology of epilepsy using a [18F]BCPP-EF PET tracer
Date of disclosure of the study information 2021/07/04
Last modified on 2023/07/06 17:19:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the pathophysiology of epilepsy using a [18F]BCPP-EF PET tracer

Acronym

Microglia and mitochondria PET

Scientific Title

Study on the pathophysiology of epilepsy using a [18F]BCPP-EF PET tracer

Scientific Title:Acronym

Microglia and mitochondria PET

Region

Japan


Condition

Condition

Epilepsy

Classification by specialty

Neurology Psychiatry Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to identify the brain regions showing altered mitochondria functions and neuroinflammation and clarify the pathophysiology of epilepsy using PET tracers for mitochondria and neuroinflammation.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Elucidation of pathophysiology of epilepsy by examining the binding of [18F]BCPP-EF and [11C]DPA713PET tracers between epilepsy and normal control group.

Key secondary outcomes

Correlation of the PET tracer binding with clinical information, electroencephalogram, neuroimaging examinations and psychological date.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

PET measurement after intravenous tracer injection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Healthy participants aged 18 to 75 years
2. Individuals who have no history of psychiatric and neurological disease
3. Individuals who are consent to participate in this study
4. Patients with epilepsy (aged 18 to 75 years)

Key exclusion criteria

1. Individuals who are suspected pregnant, pregnant or breast-feeding.
2. Individuals who have a history of claustrophobia.
3. Individuals who are considered unsuitable by doctors in charge.
4. Individuals with undergoing diabetes treatments who have the blood glucose level over 190mg/dl before PET examination.
In other day, less than 190mg/dl is enable.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yasuomi
Middle name
Last name Ouchi

Organization

Hamamatsu University School of Medicine

Division name

Department of Biofunctional Imaging

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2466

Email

ouchi@hama-med.ac.jp


Public contact

Name of contact person

1st name Yasuomi
Middle name
Last name Ouchi

Organization

Hamamatsu University School of Medicine

Division name

Department of Biofunctional Imaging

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2466

Homepage URL


Email

ouchi@hama-med.ac.jp


Sponsor or person

Institute

Department of Biofunctional Imaging,
Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Hamamatsu Medical Photonics Foundation
NHO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders
Hamamatsu Photonics

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hamamatsu University School of Medicine

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

Tel

053-435-2466

Email

ouchi@hama-med.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2020-35

Org. issuing International ID_1

NHO Shizuoka Institute of Epilepsy and Neurological Disorders

Study ID_2

No 169, C037

Org. issuing International ID_2

Hamamatsu Medical Photonics Foundation

IND to MHLW



Institutions

Institutions

浜松医科大学(静岡県)、浜松PET診断センター(静岡県)


Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 02 Month 17 Day

Date of IRB

2021 Year 02 Month 17 Day

Anticipated trial start date

2021 Year 06 Month 29 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 07 Month 04 Day

Last modified on

2023 Year 07 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050491


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name